X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (739) 739
neurosciences (672) 672
pharmacology & pharmacy (662) 662
animals (479) 479
dopamine d-2 receptor (417) 417
male (408) 408
psychiatry (393) 393
schizophrenia (375) 375
humans (358) 358
rats (336) 336
dopamine d (252) 252
dopamine d-2 receptors (250) 250
dopamine (220) 220
dopamine-d-2 receptors (209) 209
brain (182) 182
clinical neurology (176) 176
female (174) 174
receptor (162) 162
binding (161) 161
pet (144) 144
positron-emission-tomography (144) 144
haloperidol (143) 143
positron emission tomography (137) 137
dopamine d 2 receptor (133) 133
biochemistry & molecular biology (132) 132
rats, sprague-dawley (129) 129
receptors (127) 127
clozapine (126) 126
dopamine-d-2 receptor occupancy (126) 126
striatum (126) 126
receptors, dopamine d2 - metabolism (123) 123
in-vivo (117) 117
antipsychotic agents - pharmacology (116) 116
dose-response relationship, drug (116) 116
adult (112) 112
rat (110) 110
schizophrenia - drug therapy (108) 108
risperidone (107) 107
mice (102) 102
antipsychotics (101) 101
parkinsons-disease (100) 100
rat-brain (100) 100
nucleus-accumbens (98) 98
atypical antipsychotics (92) 92
antipsychotic agents - therapeutic use (89) 89
basal ganglia (87) 87
prefrontal cortex (86) 86
brain - metabolism (82) 82
aripiprazole (80) 80
double-blind (80) 80
parkinson's disease (80) 80
dopamine d-1 receptor (79) 79
antipsychotic agents - adverse effects (78) 78
behavioral sciences (77) 77
olanzapine (76) 76
chemistry, medicinal (75) 75
dopamine - metabolism (75) 75
dopamine-d-2 (75) 75
dopamine antagonists - pharmacology (74) 74
radiology, nuclear medicine & medical imaging (73) 73
antipsychotic-drugs (71) 71
drugs (70) 70
motor activity - drug effects (70) 70
pharmacology (70) 70
corpus striatum - metabolism (67) 67
antipsychotic drugs (66) 66
neurons (66) 66
antipsychotic (65) 65
schizophrenic-patients (64) 64
dopamine agonists - pharmacology (63) 63
neuroleptics (63) 63
activation (62) 62
rats, wistar (62) 62
brain - drug effects (61) 61
dopamine-d-2 receptor (61) 61
messenger-rna (61) 61
occupancy (61) 61
middle aged (60) 60
antipsychotic agents - administration & dosage (59) 59
d2 receptors (58) 58
quinpirole (58) 58
behavior, animal - drug effects (57) 57
dopamine d-2 (57) 57
article (54) 54
expression (54) 54
adenosine a receptors (53) 53
central-nervous-system (53) 53
raclopride (52) 52
release (52) 52
serotonin (52) 52
time factors (52) 52
c-11 raclopride (51) 51
corpus striatum - drug effects (51) 51
antagonist (50) 50
apomorphine (50) 50
human brain (50) 50
receptors, dopamine - drug effects (50) 50
stimulation (50) 50
agonist (49) 49
haloperidol - pharmacology (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1495) 1495
German (6) 6
French (5) 5
Japanese (5) 5
Polish (2) 2
Spanish (2) 2
Chinese (1) 1
Danish (1) 1
Italian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 8/2015, Volume 388, Issue 8, pp. 883 - 903
G-protein coupled receptors (GPCRs) are the targets of over half of all prescribed drugs today. The UniProt database has records for about 800 proteins... 
Neurosciences | CXCR 1 , CXCR 2 , CCR 4 and CCR 5 , chemokine receptors | TM, trans-membrane helix | β 2 AR, β 2 -adrenergic receptor | ProS, pairwise protein similarity method | CRF1, corticotropin releasing factor receptor 1 | T4L, T4-lysozyme | ECL, extracellular loop | GLP-1, Glucagon-like peptide-1 receptor | hM 3 R, human muscarinic M3 receptor | α1B Adrenergic receptor | Pharmacology/Toxicology | 7TM, seven-transmembrane domain | HGMP, hierarchical GPCR modelling protocol | PDB, Protein Data Bank | XFELs, x-ray free electron lasers | 5-HT 2B and 5-HT 2C , human 5-hydroxytryptamine receptors 2B and 2C, respectively | GLAS, GPCR-likeness assessment score | H 1 , histamine receptor 1 | 3D, three-dimensional | Biomedicine | CCK 2 R, cholecystokinin receptor-2 | MD, molecular dynamic simulations | GPCRs, G-protein coupled receptors | Dopamine D 2 receptor | BRIL, apocytochrome b 562 RIL | δ-OR, delta-opioid receptor | SDM, site-directed mutagenesis | CCK2R, cholecystokinin receptor-2 | PEPTIDE-1 RECEPTOR | DESIGN | CXCR1, CXCR2, CCR4, and CCR5, chemokine receptors | beta 2AR, beta 2-adrenergic receptor | hMR, human muscarinic M3 receptor | HUMAN OREXIN-1 | PHARMACOLOGY & PHARMACY | ANTAGONISTS | Dopamine D-2 receptor | PROTEIN-COUPLED RECEPTORS | SITE-DIRECTED MUTAGENESIS | alpha 1B Adrenergic receptor | LIPIDIC CUBIC PHASE | delta-OR, delta-opioid receptor | 5-HT2B and 5-HT2C, human 5-hydroxytryptamine receptors 2B and 2C, respectively | H-1, histamine receptor 1 | SERIAL FEMTOSECOND CRYSTALLOGRAPHY | BINDING | SELECTIVITY | BRIL, apocytochrome bRIL | Animals | Receptors, G-Protein-Coupled - metabolism | Computer Simulation | Drug Industry | Humans | Cooperative Behavior | Models, Molecular | Crystallography | Drug Discovery | Universities | Drug discovery | Index Medicus | BRIL, apocytochrome b562RIL | Meeting Report | H1, histamine receptor 1 | β2AR, β2-adrenergic receptor | CXCR1, CXCR2, CCR4 and CCR5, chemokine receptors | hM3R, human muscarinic M3 receptor | Dopamine D2 receptor
Journal Article
Neuropharmacology, ISSN 0028-3908, 12/2016, Volume 111, pp. 160 - 168
Journal Article
TRENDS IN NEUROSCIENCES, ISSN 0166-2236, 11/2006, Volume 29, Issue 11, pp. 647 - 654
The adenosine A(2A) receptor has emerged as an attractive non-dopaminergic target in the pursuit of improved therapy for Parkinson's disease (PD), based in... 
DOPA-INDUCED DYSKINESIA | TURNING BEHAVIOR | GLOBUS-PALLIDUS | BIOLUMINESCENCE ENERGY-TRANSFER | CENTRAL-NERVOUS-SYSTEM | 6-HYDROXYDOPAMINE-LESIONED RATS | BINDING CHARACTERISTICS | DOPAMINE-D-2 RECEPTORS | NEUROSCIENCES | C-FOS EXPRESSION | SYNERGISTIC INTERACTION | Neurosciences | Adenosine | Parkinson's disease | Research | Drug therapy
Journal Article
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, ISSN 0027-8424, 07/2015, Volume 112, Issue 27, pp. E3609 - E3618
Adenosine A(2A) receptor (A(2A)R)-dopamine D-2 receptor (D2R) heteromers are key modulators of striatal neuronal function. It has been suggested that the... 
GPCR heteromers | HETEROMERS | dopamine D-2 receptor | caffeine | DETERMINANTS | AFFINITY | MULTIDISCIPLINARY SCIENCES | COMPLEXES | adenosine A(2A) receptor
Journal Article
JOURNAL OF MEDICINAL CHEMISTRY, ISSN 0022-2623, 09/2009, Volume 52, Issue 18, pp. 5590 - 5602
Adenosine A(2A) (A(2A)R) and dopamine D-2 (D2R) receptors mediate the antagonism between adenosinergic and dopaminergic transmission in striatopallidal... 
CHEMISTRY, MEDICINAL | FLUORESCENCE | MEMBRANE | QUANTITATIVE ASSESSMENT | HIGH-AFFINITY | PROTEIN-COUPLED RECEPTORS | HETERODIMERIZATION | DOPAMINE-D-2 RECEPTORS | OLIGOMERIZATION | QUATERNARY STRUCTURE PREDICTIONS | HOMODIMERIZATION
Journal Article
Journal Article
JOURNAL OF MEDICINAL CHEMISTRY, ISSN 0022-2623, 05/2014, Volume 57, Issue 9, pp. 3623 - 3650
The adenosine A(2A) receptor is a G-protein-coupled receptor (GPCR) that has been extensively studied during the past few decades because it offers numerous... 
MEDICINAL CHEMISTRY | CHEMISTRY, MEDICINAL | POSITRON-EMISSION-TOMOGRAPHY | PHARMACOLOGICAL CHARACTERIZATION | LEAD OPTIMIZATION | STRUCTURE-AFFINITY RELATIONSHIPS | SELECTIVE AGONISTS | ALLOSTERIC MODULATION | BINDING CHARACTERISTICS | DOPAMINE-D-2 RECEPTORS | PARKINSONS-DISEASE
Journal Article
by Gao, J and Chen, LL and Li, M
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, ISSN 0091-3057, 05/2019, Volume 180, pp. 32 - 43
Serotonin 5-HT2A receptors are expressed throughout the mesolimbic and mesocortical dopamine pathways, and manipulation of this receptor system has a profound... 
Serotonin 2A receptor | Dopamine D-2 receptor | HALOPERIDOL | BEHAVIOR | Pup preference | LOW DOSAGES | NEUROSCIENCES | NUCLEUS-ACCUMBENS | Maternal behavior | Emotional processing | Incentive motivation | FEMALE RATS | MEDIAL PREFRONTAL CORTEX | ANTIPSYCHOTIC-DRUGS | ATTENTIONAL PERFORMANCE | BEHAVIORAL SCIENCES | PHARMACOLOGY & PHARMACY | NEURAL MECHANISMS | PUP-RETRIEVAL
Journal Article
15.